Page 33 - Ischemic Stroke News Today

In a recent study under review in the Nature Portfolio journal and currently available on the Research Square* preprint server, researchers investigated the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (SP) in the thrombi (or blood clots).

The largest trial so far conducted with the new bolus thrombolytic, tenecteplase, in acute ischemic stroke has shown noninferiority to alteplase with similar safety.

The NOR-TEST 2A trial was stopped after increased rates of ICH and mortality were seen in the group assigned to tenecteplase 0.4 mg/kg compared with the standard dose of alteplase.

Giving the bolus thrombolytic tenecteplase in a mobile stroke unit improved efficacy compared with the standard of care thrombolytic alteplase, without safety concerns, in the TASTE-A study.

Women with systemic lupus erythematosus (SLE) were 20% more likely to have a prolonged hospital stay and 28% less likely to have a routine home discharge, compared with patients who did not have SLE.

A recent article posted in the Journal of the American Medical Association (JAMA) analyzed aspirin use to prevent cardiovascular disease (CVD) and colorectal cancer (CRC).

Data suggest that increases in ambient levels of fine particulate matter, nitrogen dioxide, and black carbon increase the risk for ischemic stroke, regardless of age, smoking status, or other factors.

Germany: In a new study published in the Journal of Thrombosis and Haemostasis it has been revealed that monitoring direct oral anticoagulant (DOAC) plasma levels may aid in identifying individuals at...

A new study has prompted scientists to reconsider a once-popular yet controversial idea in stroke research.

In a Mendelian randomization study, Andrew B. Linden and colleagues study the relationship between height and risk of stroke subtypes among individuals from the MEGASTROKE consortium, China Kadoorie Biobank, and UK Biobank.